Rong, Z. ; Mai, H. ; Ebert, G. ; Kapoor, S. ; Puelles, V.G.* ; Czogalla, J.* ; Hu, S.* ; Su, J. ; Prtvar, D.* ; Singh, I. ; Schädler, J.* ; Delbridge, C.* ; Steinke, H.* ; Frenzel, H.* ; Schmidt, K.* ; Braun, C.* ; Bruch, G.* ; Ruf, V.* ; Ali, M. ; Sühs, K.W.* ; Nemati, M.* ; Hopfner, F.* ; Ulukaya, S. ; Jeridi, D. ; Mistretta, D. ; Caliskan, Ö.S. ; Wettengel, J.M. ; Cherif, F.* ; Kolabas, Z.I. ; Molbay, M. ; Horvath, I. ; Zhao, S. ; Krahmer, N. ; Yildirim, A.Ö. ; Ussar, S. ; Herms, J.* ; Huber, T.B.* ; Tahirovic, S.* ; Schwarzmaier, S.M.* ; Plesnila, N.* ; Höglinger, G.* ; Ondruschka, B.* ; Bechmann, I.* ; Protzer, U. ; Elsner, M. ; Bhatia, H.S. ; Hellal, F. ; Ertürk, A.
Persistence of spike protein at the skull-meninges-brain axis may contribute to the neurological sequelae of COVID-19.
Cell Host Microbe 32, 2112-2130.e10 (2024)
SARS-CoV-2 infection is associated with long-lasting neurological symptoms, although the underlying mechanisms remain unclear. Using optical clearing and imaging, we observed the accumulation of SARS-CoV-2 spike protein in the skull-meninges-brain axis of human COVID-19 patients, persisting long after viral clearance. Further, biomarkers of neurodegeneration were elevated in the cerebrospinal fluid from long COVID patients, and proteomic analysis of human skull, meninges, and brain samples revealed dysregulated inflammatory pathways and neurodegeneration-associated changes. Similar distribution patterns of the spike protein were observed in SARS-CoV-2-infected mice. Injection of spike protein alone was sufficient to induce neuroinflammation, proteome changes in the skull-meninges-brain axis, anxiety-like behavior, and exacerbated outcomes in mouse models of stroke and traumatic brain injury. Vaccination reduced but did not eliminate spike protein accumulation after infection in mice. Our findings suggest persistent spike protein at the brain borders may contribute to lasting neurological sequelae of COVID-19.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publikationstyp
Artikel: Journalartikel
Dokumenttyp
Wissenschaftlicher Artikel
Typ der Hochschulschrift
Herausgeber
Schlagwörter
Sars-cov-2 ; Brain ; Long Covid ; Mrna Vaccine ; Meninges ; Neurodegeneration ; Neuroinflammation ; Skull ; Spike Protein ; Tissue Clearing; Neutrophil Extracellular Traps; Controlled Cortical Impact; Ischemic-stroke; Coronavirus; Craniotomy; Proteomics; Receptor; Injury; Route; Cells
Keywords plus
Sprache
englisch
Veröffentlichungsjahr
2024
Prepublished im Jahr
0
HGF-Berichtsjahr
2024
ISSN (print) / ISBN
1931-3128
e-ISSN
1934-6069
ISBN
Bandtitel
Konferenztitel
Konferzenzdatum
Konferenzort
Konferenzband
Quellenangaben
Band: 32,
Heft: 12,
Seiten: 2112-2130.e10
Artikelnummer: ,
Supplement: ,
Reihe
Verlag
Elsevier
Verlagsort
50 Hampshire St, Floor 5, Cambridge, Ma 02139 Usa
Tag d. mündl. Prüfung
0000-00-00
Betreuer
Gutachter
Prüfer
Topic
Hochschule
Hochschulort
Fakultät
Veröffentlichungsdatum
0000-00-00
Anmeldedatum
0000-00-00
Anmelder/Inhaber
weitere Inhaber
Anmeldeland
Priorität
Begutachtungsstatus
Peer reviewed
POF Topic(s)
30205 - Bioengineering and Digital Health
30203 - Molecular Targets and Therapies
30201 - Metabolic Health
90000 - German Center for Diabetes Research
30202 - Environmental Health
Forschungsfeld(er)
Enabling and Novel Technologies
Immune Response and Infection
Helmholtz Diabetes Center
Lung Research
PSP-Element(e)
G-505800-001
G-502700-010
G-502700-003
G-502296-001
G-501900-221
G-505000-007
G-502799-701
Förderungen
European Research Council Consolidator grant
NOMIS Hu-man Heart Atlas Project grant (Nomis Foundation)
Vascular Dementia Research Foundation
Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) under Germany's Excellence Strategy within the frame-work of the Munich Cluster for Systems Neurology
German Federal Ministry of Education and Research
(BMBF)
DFG
State of Bavaria
European Union
Helmholtz Association's Initiative and Networking Fund
GoBio project
China Scholarship Council (CSC)
Copyright
Erfassungsdatum
2024-12-06